These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19197128)

  • 1. [Resistance by hypermutable Pseudomonas aeruginosa and beta-lactamases production].
    Cao W; Yao D; Zheng R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):54-8. PubMed ID: 19197128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemical and genetical mechanisms in emergence of multidrug-resistant Pseudomonas aeruginosa (MDRP)].
    Noguchi K; Gotoh N
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():457-62. PubMed ID: 17455662
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey.
    Yakupogullari Y; Poirel L; Bernabeu S; Kizirgil A; Nordmann P
    J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
    Bonomo RA; Szabo D
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S49-56. PubMed ID: 16894515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nosocomial bloodstream infections due to metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Zavascki AP; Barth AL; Goldani LZ
    J Antimicrob Chemother; 2008 May; 61(5):1183-5. PubMed ID: 18319237
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the drug resistance and beta-lactamases of Pseudomonas aeruginosa].
    Wang J; Zhou JY; Yu YS
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):258-62. PubMed ID: 15854438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of dissemination of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in hospitals: present and future].
    Oliver A
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):255-6. PubMed ID: 19361889
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial resistance profile of Pseudomonas aeruginosa producing metallo-beta-lactamases.
    Agarwal VA; Dongre SA; Powar RM
    Indian J Med Res; 2006 Nov; 124(5):588-90. PubMed ID: 17213530
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.
    Zhao WH; Hu ZQ
    Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of an imported extremely-resistant Pseudomonas aeruginosa producing three different extended-spectrum β-lactamases and hyperproducing two multidrug-efflux pumps.
    Ratkai C; Nagy E; Peixe L; Bertalan V; Hajdú E
    J Infect; 2010 Dec; 61(6):511-2. PubMed ID: 20951729
    [No Abstract]   [Full Text] [Related]  

  • 11. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
    Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C
    Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrons and beta-lactamases--a novel perspective on resistance.
    Weldhagen GF
    Int J Antimicrob Agents; 2004 Jun; 23(6):556-62. PubMed ID: 15194125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
    J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
    Wang C; Cai P; Chang D; Mi Z
    J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ; Hsueh PR; Lu JJ; Chang FY; Ko WC; Wu JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):530-6. PubMed ID: 16816399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran.
    Khosravi AD; Mihani F
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea.
    Suk SE; Yoo JS; Lee JK; Lee KM; Chung GT; Shin ES; Han SY; Lee SH; Kim J; Lee YS
    J Microbiol Biotechnol; 2007 Oct; 17(10):1733-7. PubMed ID: 18156795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro action of new beta-lactams on hospital strains of Pseudomonas aeruginosa producing beta-lactamases ].
    Moillo-Batt A; Shacoori ZT
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):510-2. PubMed ID: 6812004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF; El-Domany RA; Zaki S; Ashour HM
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-lactamase producing Pseudomonas aeruginosa in hospitalised patients.
    Pandey A; Malenie R; Asthana AK
    Indian J Pathol Microbiol; 2005 Oct; 48(4):530-3. PubMed ID: 16366119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.